SEC Form 4 · accession 0001179110-16-031087
ABIOMED INC · ABMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William J Bolt
Officer — SVP, QA and Regulatory Affairs
Period of report
Oct 31, 2016
Accepted (ET)
Nov 2, 2016 · 4:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000815094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 parF5 | Oct 31, 2016 | M | 5,000 | $22.44 | A | 78,687 | D | |
| Common Stock, $.01 parF5 | Oct 31, 2016 | M | 15,000 | $23.15 | A | 93,687 | D | |
| Common Stock, $.01 parF5 | Oct 31, 2016 | M | 10,000 | $21.55 | A | 103,687 | D | |
| Common Stock, $.01 parF5,F6 | Oct 31, 2016 | S | 7,900 | $103.0825 | D | 95,787 | D | |
| Common Stock, $.01 parF5,F7 | Oct 31, 2016 | S | 30,849 | $104.0001 | D | 64,938 | D | |
| Common Stock, $.01 parF5,F8 | Oct 31, 2016 | S | 4,617 | $104.4986 | D | 60,321 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2,F5,F1 | $22.44 | Oct 31, 2016 | M | 5,000 | D | May 22, 2013 | May 22, 2022 | Common Stock | 0 | 0 | D |
| Stock Option (Right to Buy)F2,F5,F1 | $23.15 | Oct 31, 2016 | M | 15,000 | D | May 14, 2014 | May 14, 2023 | Common stock | 20,000 | 5,000 | D |
| Stock Option (Right to Buy)F2,F5,F3 | $21.55 | Oct 31, 2016 | M | 10,000 | D | May 14, 2015 | May 14, 2024 | Common Stock | 15,000 | 5,000 | D |
| Stock Option (Right to Buy)F2,F3 | $66.25 | holding | — | — | — | May 13, 2016 | May 13, 2025 | Common Stock | 0 | 6,000 | D |
| Stock Option (Right to Buy)F4,F3 | $99.62 | holding | — | — | — | May 24, 2017 | May 24, 2026 | Common Stock | 0 | 5,000 | D |
Explanation of responses
- F1These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
- F2Grant to reporting person of this option to buy the number of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- F3These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
- F4Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
- F5Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- F6This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $102.4300 and $103.4200. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F7This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $103.4300 and $104.4200. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F8This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $104.4300 and $104.7600. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.